Special Notice Posted!

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases          Visit us on the Web The NIAID Radiation/Nuclear Countermeasures Program (RNCP) supports extramural research to develop safe and effective radiation medical countermeasures and biodosimetry methods and/or devices for clinical use under emergency situations. A Special Notice was recently posted for the following solicitation: Development of Radiation/Nuclear Medical Countermeasures (Solicitation Number: HHS-NIH-NIAID-BAA2019-1) The goal of this research is to support the development of safe and effective Medical Countermeasures (MCMs) to mitigate and/or treat tissue injuries exposure to ionizing radiation from a radiological or nuclear incident, thereby leading to a reduction in radiation-associated morbidities and mortalities. Given the extent of damage sustained after a mass casualty incident, drugs are not expected to be mobilized from the Strategic National Stockpile before 24 hours, hence the need for MCMs that are efficacious 24 hours or later post-exposure. Visit FedBizOpps.gov to download the Special Notice for HHS-NIH-NIAID-BAA2019-1. Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107